CDH2 and neoplasm: Immunohistochemical staining of these tumors confirmed higher expression of the proliferation marker Ki-67 and mesenchymal markers N-cadherin and vimentin, alongside reduced levels of E-cadherin, suggesting increased tumor aggressiveness and enhanced EMT characteristics (Fig. S2F).